Matinas BioPharma
in tumor cell inhibition with formulations rationale and next steps | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
21 of 29
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
February 2024
in tumor cell inhibition with formulations rationale and next steps | Matinas BioPharma
Investor Presentation
November 2023
in tumor cell inhibition with formulations | Matinas BioPharma
Related slides by other companies
SentiBio
SPAC
October 2021
armed car cells exhibit significantly improved killing of cancer cells a in tumor cell day post culture ratio i | SentiBio
SentiBio
SPAC
October 2021
or car cells significantly suppressed tumor growth reduced tumor burden and improved survival cancer bice model | SentiBio
Mink Therapeutics
Investor Day
November 2022
car enhances infiltration of tumor specific cells to clear tumor mink | Mink Therapeutics
Immatics
Investor Presentation
November 2023
format is designed for optimized efficacy and safety | Immatics
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io